Olvert A Berkhemer1, Lucie A van den Berg1, Puck S S Fransen1, Debbie Beumer1, Albert J Yoo1, Hester F Lingsma1, Wouter J Schonewille1, René van den Berg1, Marieke J H Wermer1, Jelis Boiten1, Geert J Lycklama À Nijeholt1, Paul J Nederkoorn1, Markus W Hollmann1, Wim H van Zwam1, Aad van der Lugt1, Robert J van Oostenbrugge1, Charles B L M Majoie1, Diederik W J Dippel1, Yvo B W E M Roos2. 1. From the Departments of Radiology (O.A.B., R.v.d.B., C.B.L.M.M.), Neurology (L.A.v.d.B., P.J.N., Y.B.W.E.M.R.), and Anesthesiology (M.W.H.), Academic Medical Center, Amsterdam; Departments of Radiology (P.S.S.F., A.v.d.L.), Neurology (O.A.B., P.S.S.F., D.W.J.D.), and Public Health (H.F.L.), Erasmus MC University Medical Center, Rotterdam; Departments of Radiology (W.H.v.Z.) and Neurology (D.B., R.J.v.O.), Maastricht University Medical Center and Cardiovascular Research Institute Maastricht (CARIM), the Netherlands; Division of Neurointervention (A.J.Y.), Texas Stroke Institute, Plano; Department of Neurology (W.J.S.), Sint Antonius Hospital, Nieuwegein; Department of Neurology (M.J.H.W.), Leiden University Medical Center; and Departments of Neurology (J.B.) and Radiology (G.J.L.à.N.), MC Haaglanden, the Hague, the Netherlands. 2. From the Departments of Radiology (O.A.B., R.v.d.B., C.B.L.M.M.), Neurology (L.A.v.d.B., P.J.N., Y.B.W.E.M.R.), and Anesthesiology (M.W.H.), Academic Medical Center, Amsterdam; Departments of Radiology (P.S.S.F., A.v.d.L.), Neurology (O.A.B., P.S.S.F., D.W.J.D.), and Public Health (H.F.L.), Erasmus MC University Medical Center, Rotterdam; Departments of Radiology (W.H.v.Z.) and Neurology (D.B., R.J.v.O.), Maastricht University Medical Center and Cardiovascular Research Institute Maastricht (CARIM), the Netherlands; Division of Neurointervention (A.J.Y.), Texas Stroke Institute, Plano; Department of Neurology (W.J.S.), Sint Antonius Hospital, Nieuwegein; Department of Neurology (M.J.H.W.), Leiden University Medical Center; and Departments of Neurology (J.B.) and Radiology (G.J.L.à.N.), MC Haaglanden, the Hague, the Netherlands. y.b.roos@amc.uva.nl.
Abstract
BACKGROUND: The aim of the current study was to assess the influence of anesthetic management on the effect of treatment in the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN). METHODS: MR CLEAN was a multicenter, randomized, open-label trial of intra-arterial therapy (IAT) vs no IAT. The intended anesthetic management at the start of the procedure was used for this post hoc analysis. The primary effect parameter was the adjusted common odds ratio (acOR) for a shift in direction of a better outcome on the modified Rankin Scale (mRS) at 90 days, estimated with multivariable ordinal logistic regression analysis, which included a term for general anesthesia (GA). RESULTS: GA was associated with significant (p = 0.011) effect modification, resulting in estimated decrease of 51% (95% confidence interval [CI] 31%-86%) in treatment effect compared to non-GA. We found a shift in the distribution on the mRS in favor of non-GA compared to control group (acOR 2.18 [95% CI 1.49-3.20]). The shift in distribution between GA and control group was in a similar direction (acOR 1.12 [95% CI 0.71-1.78]) with loss of statistical significance. CONCLUSIONS: In this post hoc analysis, we found that the type of anesthetic management influences outcome following IAT. Only treatment without general anesthesia was associated with a significant treatment benefit in MR CLEAN. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for patients with acute ischemic stroke undergoing IAT, mRS scores at 90 days improve only in patients treated without GA.
RCT Entities:
BACKGROUND: The aim of the current study was to assess the influence of anesthetic management on the effect of treatment in the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN). METHODS: MR CLEAN was a multicenter, randomized, open-label trial of intra-arterial therapy (IAT) vs no IAT. The intended anesthetic management at the start of the procedure was used for this post hoc analysis. The primary effect parameter was the adjusted common odds ratio (acOR) for a shift in direction of a better outcome on the modified Rankin Scale (mRS) at 90 days, estimated with multivariable ordinal logistic regression analysis, which included a term for general anesthesia (GA). RESULTS: GA was associated with significant (p = 0.011) effect modification, resulting in estimated decrease of 51% (95% confidence interval [CI] 31%-86%) in treatment effect compared to non-GA. We found a shift in the distribution on the mRS in favor of non-GA compared to control group (acOR 2.18 [95% CI 1.49-3.20]). The shift in distribution between GA and control group was in a similar direction (acOR 1.12 [95% CI 0.71-1.78]) with loss of statistical significance. CONCLUSIONS: In this post hoc analysis, we found that the type of anesthetic management influences outcome following IAT. Only treatment without general anesthesia was associated with a significant treatment benefit in MR CLEAN. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for patients with acute ischemic stroke undergoing IAT, mRS scores at 90 days improve only in patients treated without GA.
Authors: Rob A van de Graaf; Noor Samuels; Maxim J H L Mulder; Ismail Eralp; Adriaan C G M van Es; Diederik W J Dippel; Aad van der Lugt; Bart J Emmer Journal: Neurology Date: 2018-06-01 Impact factor: 9.910
Authors: C J Powers; D Dornbos; M Mlynash; D Gulati; M Torbey; S M Nimjee; M G Lansberg; G W Albers; M P Marks Journal: AJNR Am J Neuroradiol Date: 2019-05-09 Impact factor: 3.825
Authors: F Flottmann; H Leischner; G Broocks; T D Faizy; A Aigner; M Deb-Chatterji; G Thomalla; J Krauel; M Issleib; J Fiehler; C Brekenfeld Journal: AJNR Am J Neuroradiol Date: 2019-12-05 Impact factor: 3.825